Your browser doesn't support javascript.
loading
Botulinum toxin A for refractory OAB and idiopathic urinary retention: Can phenotyping improve outcome for patients: ICI-RS 2019?
Malde, Sachin; Apostilidis, Apostolos; Selai, Caroline; Rahnama'i, Mohammad Sajjad; Marcelissen, Tom; Cardozo, Linda; Lovick, Thelma.
Afiliação
  • Malde S; Department of Urology, Guy's Hospital, London, UK.
  • Apostilidis A; 2nd Department of Urology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Selai C; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
  • Rahnama'i MS; Department of Urology, Uniklinik Aachen RWTH, Aachen, Germany.
  • Marcelissen T; Department of Urology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Cardozo L; Department of Urology, Uniklinik Aachen RWTH, Aachen, Germany.
  • Lovick T; Department of Urogynaecology, King's College Hospital, London, UK.
Neurourol Urodyn ; 39 Suppl 3: S104-S112, 2020 07.
Article em En | MEDLINE | ID: mdl-31692092
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Retenção Urinária / Toxinas Botulínicas Tipo A / Bexiga Urinária Hiperativa / Fármacos Neuromusculares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Retenção Urinária / Toxinas Botulínicas Tipo A / Bexiga Urinária Hiperativa / Fármacos Neuromusculares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article